[(Name of Issuer) Ordinary Shares, Par Value $0.00005 Per Ordinary Share, and American Depositary Shares, Each Representing 100 Ordinary Shares (Title of Class of Securities) 447773 10 2 (CUSIP Number) Grace Wu Chief Financial Officer Shanda Interactive Entertainment Limited No. 208 Juli Road Pudong New Area Shanghai 201203, People’s Republic of China Telephone: (86-21) 5050-4740 (Name, Address and Telephone Number]
[(Name of Issuer) Ordinary Shares, Par Value $0.00005 Per Ordinary Share, and American Depositary Shares, Each Representing 100 Ordinary Shares (Title of Class of Securities) 447773 10 2 (CUSIP Number) Grace Wu Chief Financial Officer Shanda Interactive Entertainment Limited No. 208 Juli Road Pudong New Area Shanghai 201203, People’s Republic of China Telephone: (86-21) 5050-4740 (Name, Address and Telephone Number]
[Form 6-K TABLE OF CONTENTS Page 3 Further Announcement on the Progress of Payment of Final Dividends for H Shares for Year 2010 4 2]
[Form 6-K TABLE OF CONTENTS Page 3 Further Announcement on the Progress of Payment of Final Dividends for H Shares for Year 2010 4 2]
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 July 7, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 July 7, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 July 7, 2011 Accounting Branch 100 F. Street, N.E. Attn: Joel Parker Re: Tianyin Pharmaceutical Co., Inc. Item 4.02, Form 8-K filed June 16, 2011 File No. 001-34189 Dear Mr. Parker: This letter is provided in response to your letter dated June 23, 2011 regarding the above-referenced Form 8-K for Tianyin]
[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 July 7, 2011 Accounting Branch 100 F. Street, N.E. Attn: Joel Parker Re: Tianyin Pharmaceutical Co., Inc. Item 4.02, Form 8-K filed June 16, 2011 File No. 001-34189 Dear Mr. Parker: This letter is provided in response to your letter dated June 23, 2011 regarding the above-referenced Form 8-K for Tianyin]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K/A CURRENT REPORT June 10, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation Indentification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Item 4 –]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K/A CURRENT REPORT June 10, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation Indentification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Item 4 –]
